In vivo amplification of the androgen receptor gene and progression of human prostate cancer
1995 · Nature Genetics · 1,479 citations
https://doi.org/10.1038/ng0495-401
J
Jorma Isola
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
395
Papers
31.8K
Citations
92
h-index
253
i10-index
Jorma Isola is an academic researcher from Tampere University of Applied Sciences. The author has contributed to research in topics: HER2/EGFR in Cancer Research & Monoclonal and Polyclonal Antibodies Research & Breast Cancer Treatment Studies. The author has an h-index of 92, co-authored 336 publications.
ORCID: 0000-0002-0849-5939Papers by this author
worksAdjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer
2006 · New England Journal of Medicine · 1,405 citations
https://doi.org/10.1056/nejmoa053028
Trastuzumab emtansine: mechanisms of action and drug resistance
2014 · Breast Cancer Research · 570 citations
https://doi.org/10.1186/bcr3621
Decreased Accessibility and Lack of Activation of ErbB2 in JIMT-1, a Herceptin-Resistant, MUC4-Expressing Breast Cancer Cell Line
2005 · Cancer Research · 510 citations
https://doi.org/10.1158/0008-5472.473.65.2
ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67
2010 · Breast Cancer Research · 467 citations
https://doi.org/10.1186/bcr2615
Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer Trial
2009 · Journal of Clinical Oncology · 458 citations
https://doi.org/10.1200/jco.2008.21.4577
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat